InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: shell3 post# 16202

Thursday, 09/08/2022 12:46:47 PM

Thursday, September 08, 2022 12:46:47 PM

Post# of 16699
Yes, here is the Golden Ticket...IMO...GLTA...

"The Company has now completed its intravenous formulation (“IVF”) that will be used in the Phase 1 DMT study. The formulation was developed by the Centre for Human Drug Research (“CHDR”) and its affiliated pharmacy at the Leiden University Medical Center in the Netherlands. The Company has applied for ethics and clinical trial approval and is expecting to have a response shortly."